Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model

BACKGROUND: The purpose of this study was to evaluate the safety and efficacy of thymosin beta 4 ophthalmic solution (RGN-259; Tβ4) in subjects with moderate to severe dry eye using the CAE™ model. METHODS: This single-center, prospective, double-masked, placebo-controlled Phase II study randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Sosne, Gabriel, Ousler, George W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445951/
https://www.ncbi.nlm.nih.gov/pubmed/26056426
http://dx.doi.org/10.2147/OPTH.S80954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445951/
https://www.ncbi.nlm.nih.gov/pubmed/26056426
http://dx.doi.org/10.2147/OPTH.S80954

Ejemplares similares